BOSTON, Aug. 17, 2022 /PRNewswire/ -- Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, announced that a study it coauthored helped support ...
The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...
Analysis utilizing GuardantINFORM™ real-world evidence platform shows cumulative incidence of EGFR C797X mutation was 12.5 percent in NSCLC patients likely to progress after first-line osimertinib ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the introduction of a three-year plan to add GS1 Data Matrix barcodes to its pharmaceutical portfolio of vials, syringes, IV ...
The treatment also reduced the risk of progression to the next stage of Alzheimer’s disease by 28% (95% CI: 0.59, 0.87) over 36 months compared to the ADNI cohort, as measured by CDR-SB 1 These data ...
MedPage Today on MSN
FDA to Pull Boxed Warning on Menopausal Hormone Therapy
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback